SCHEMBL498209

SCHEMBL498209

[CH2]CCCc1cc(-c2ccco2)co1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.39
PRMT6 Q96LA8 1/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 4/20 0.36
USP2 O75604 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
KEAP1 Q14145 1/20 0.35
KDM4E B2RXH2 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPT P10636 3/20 0.33
BLM P54132 2/20 0.33
POLB P06746 2/20 0.33
ALOX15 P16050 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
PKM P14618 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5541566 0.79 CTRC (0.36) ALDH1A1HPGDUSP2TDP1
SCHEMBL497767 0.77 CHRNA4 (0.33) ALDH1A1USP2HSD17B10ALOX15MEN1
SCHEMBL5535282 0.75 CTRC (0.35) ALDH1A1HPGDUSP2TDP1ALOX15
SCHEMBL5543970 0.73 ALDH1A1 (0.36) ALDH1A1HPGDUSP2TDP1ALOX15
SCHEMBL5545899 0.73 ALDH1A1 (0.32) ALDH1A1USP2KDM4ENPC1RAB9A
SCHEMBL5539424 0.73 MAOB (0.33) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL5542932 0.73 MAOB (0.40) TAAR1ALDH1A1NPC1RAB9ATP53
SCHEMBL270348 0.72
SCHEMBL28578708 0.70 TAAR1 (0.48) TAAR1PRMT6ALDH1A1HPGDUSP2
SCHEMBL5544415 0.69 MAOB (0.39) TAAR1ALDH1A1NPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157084-B1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE KOWA CO (JP) 2013-05-22 EP disclosed
US-8106053-B2 5-phenyl-3-pyridazinone derivative KOWA COMPANY, LTD. 2012-01-31 US disclosed
US-20100197698-A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE KOWA COMPANY, LTD. (JP) 2010-08-05 US disclosed
EP-2157084-A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE Kowa Company, Ltd. (JP) 2010-02-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197698-A1 5-PHENYL-3-PYRIDAZINONE DERIVATIVE SERPINE1, MMP1, PLAT TAAR1 4570/4885PRMT6 4196/4885ALDH1A1 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.